Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Linneo Health and Phytocontrol Group sign exclusive medicinal cannabis clinical analysis collaboration agreement
Tuesday, December 13, 2022Linneo Health a global leader in the research cultivation and supply of cannabis to improve human health and wellbeing and Phytocontrol an international group of laboratories
Calliditas Therapeutics announces license agreement with Viatris to register and commercialize specialty therapy for IgA nephropathy in Japan
Tuesday, December 13, 2022Calliditas Therapeutics AB announced today that they have entered into an exclusive license agreement with Viatris Pharmaceuticals Japan Inc a subsidiary of Viatris Inc to register and commercialize Nefecon a specialty drug recently approved in Europ...
Sosei Heptares Receives $10 Million Milestone Payment in Discovery Collaboration with AbbVie Targeting Inflammatory Diseases
Monday, December 12, 2022Sosei Group Corporation the world leader in G proteincoupled receptor GPCR focused structurebased drug design SBDD and development announces that it has reached an important RD milestone under its discovery collaboration with AbbVie the global biopha...
Karyopharm Announces Presentation of Updated Phase 1 Selinexor Data in Patients with Treatment-Naïve Myelofibrosis at ASH 2022
Monday, December 12, 2022Karyopharm Therapeutics Inc a commercialstage pharmaceutical company pioneering novel cancer therapies today announced updated results from the Phase portion of its study evaluating the safety and efficacy of onceweekly selinexor in combination with...
AcelRx Pharmaceuticals Announces European Peer-Reviewed Publication Supporting the Benefits of Sublingual Sufentanil Tablets For Post-Operative Pain Management
Thursday, December 08, 2022AcelRx Pharmaceuticals Inc a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings today announced a recent retrospective study published in the Journal of C...
Ipsen Provides Update On Phase III CONTACT-01 Trial Evaluating Cabozantinib in Combination With Atezolizumab in Patients With Metastatic Non-small Cell Lung Cancer
Thursday, December 08, 2022Ipsen announced today that the CONTACT study did not meet its primary endpoint of overall survival OS at the final analysis CONTACT is a phase III clinical trial evaluating Cabometyx cabozantinib in combination with atezolizumab Tecentriq versus doce...
Cenobamate (ONTOZRY®), for the Treatment of Uncontrolled Focal-onset Seizures in Adults, Is Now Available in France and Belgium
Wednesday, December 07, 2022Angelini Pharma international pharmaceutical company part of the privately held Italian Angelini Group today announced that ONTOZRY cenobamate is now available in France and Belgium for the adjunctive treatment of focalonset seizures with or without...
Apogee Therapeutics Launches with $169 Million to Develop Potentially Best-in-Class Therapies for Immunological and Inflammatory Disorders
Wednesday, December 07, 2022Apogee Therapeutics LLC a biotechnology company advancing novel potentially bestinclass therapies to address the needs of the millions of people living with immunological and inflammatory disorders today announced the closing of a million Series B f...
Lonza’s API Mid-Scale Manufacturing Facility Expansion in Nansha Enters Commercial Operation
Tuesday, December 06, 2022Lonza today announces the start of new midscale manufacturing assets at its API manufacturing center in Nansha China Commercial midscale operations are now underway at the expanded manufacturing facility which was part of a CHF million investment an...
Coriolis Pharma Appoints Formulation and Drug Development Expert Bruce Kerwin to Scientific Advisory Board
Tuesday, December 06, 2022Coriolis Pharma a globally operating service provider and one of the world leaders in formulation research and development of biopharmaceutical drugs including cell and gene therapy products and vaccines is strengthening its scientific advisory board...
